High-throughput drug screening in advanced pre-clinical 3D melanoma models identifies potential first-line therapies for NRAS-mutated melanoma

Cristian Angeli(University of Luxembourg), Stephanie Kreis(University of Luxembourg)
Research Square
May 15, 2025
Cited by 0


Related Papers